Use of GLP1RAs and occurrence of respiratory disorders: A meta-analysis of large randomized trials of GLP1RAs.

Jin-Ping WeiChang-Lin YangWen-Hua LengLiang-Liang DingGuo-Hou Zhao

Published in: The clinical respiratory journal (2021)

GLP1RAs show the reduced trends in the risks of nine kinds of respiratory disorders (eg, pneumonia, SCCL, asthma, and COPD), but the increased trend in the risk of ILD. However, these findings need to be validated by further studies due to the low incidence rates of all the respiratory disorders.

Keyphrases

chronic obstructive pulmonary disease
wild type
lung function
risk assessment
respiratory tract
risk factors
interstitial lung disease
intensive care unit
cystic fibrosis
rheumatoid arthritis
climate change
idiopathic pulmonary fibrosis
extracorporeal membrane oxygenation